Lead sponsor

University of California, San Diego

2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

2

Trials led

0

Active

210

Total enrollment

2

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2
1
Not applicable
1

Trials by status

Completed
1
Unknown
1

Trials led

SAMARABMI ≥27Ph 2Unknown120
GLP-1 Medicines and Mental Health Changesnot applicableCompleted90